The Equine Healthcare Market report is equipped with market data from 2013 to 2023. The report gives a market overview covering key drivers and risks factors. The report is bifurcated by top global manufactures mentioning sales, revenue and prices as applicable. It also evaluates the competitive scenario of the leading players. The report expands to cover regional market data along with type and application. The report forecasts sales and revenue from 2018 to 2023. The detailed sales channel is also covered in the study.
Equine health refers to veterinary services intended to treat horses to enhance their quality of life, increase their lifespan, and develop better quality animal food.
Scope of the Report:
This report studies the Equine Healthcare market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Equine Healthcare market by product type and applications/end industries.
Based on therapeutic product types this market can be classified into equine therapeutics market and equine vaccines market. These have many other products including various vaccines, anti-bacterial, anti-viral anti-protozoal, laxatives and dopamine.
Based on diagnostic products types this market is classified into equine pregnancy and gestation diagnostic products and equine genotyping analysis products.
The global Equine Healthcare market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Equine Healthcare.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
- Affymetrix
- Bayer Health Care
- Boehringer Ingelheim
- Elanco Animal Health
- Merck Animal Health
- Purina Animal
- Zoetis
- Boerhringer Ingelheim Vetmedica
- Ceva Holdings
- Merial
- Novartis Animal Health
- Signostics
- Vetoquinol
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Equine Diagnostic Products
- Equine Therapeutic Products
- Equine Genotype Analysis
- Others
Market Segment by Applications, can be divided into
- Veterinary Clinics
- Animal Science Research Institute
- Others